With innovation driving yet another Irish start-up to succeed in Europe, the factors shaping Ireland’s thriving medtech sector are increasingly in international demand.
Irish start-up Bluedrop Medical has won the prestigious URGO Mentorship Program in France. Urgo Group, which specialises in wound treatment, announced the winner in March 2018.
CEO of France’s URGO Group, Pierre Moustial, commented, “Bluedrop Medical’s positioning regarding diabetic foot ulcers is in perfect synergy with URGO, and in alignment with the recent positive results of our own clinical trials.”
The innovative solution developed by Bluedrop Medical will help to prevent amputations caused by diabetic foot ulcers.
Ireland’s medtech cluster
Ireland’s successful collaborations with international partners are supported by its cluster of 300 medtech companies, 60% of which are actively involved in research, development and innovation.
The ecosystem is further strengthened by the presence of 18 of the world’s 25 largest medtech multinationals. Years of supplying to, and servicing the needs of, major multinationals have enabled Irish medtech companies to develop expertise that operates on a global scale.
Ranking first in the world for attracting and retaining talent in IMD’s 2017 Global Competitiveness Yearbook, Ireland is the biggest employer of medtech professionals per capita in Europe.
Jean-Charles Moczarski, Enterprise Ireland market advisor with a focus on medtech and located in Paris, has assisted many international companies like URGO Group in sourcing innovative Irish partners. He comments, “Ireland is a key partner for global health leaders and Ireland’s medical technology ecosystem is among one of most innovative in Europe.”
Buyers in search of pioneering innovations, access to the world’s best medtech companies, and an ecosystem of research expertise are increasingly turning to Ireland to source their competitive advantage.